Literature DB >> 9158466

Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men.

A G Shaper1, S G Wannamethee, M Walker.   

Abstract

OBJECTIVE: To determine the body mass index associated with the lowest morbidity and mortality.
DESIGN: Prospective study of a male cohort.
SETTING: One general practice in each of 24 British towns.
SUBJECTS: 7735 men aged 40-59 years at screening. MAIN OUTCOME MEASURES: All cause death rate, heart attacks, and stroke (fatal and non-fatal) and development of diabetes, or any of these outcomes (combined end point) over an average follow up of 14.8 years.
RESULTS: There were 1271 deaths from all causes, 974 heart attacks, 290 strokes, and 245 new cases of diabetes mellitus. All cause mortality was increased only in men with a body mass index (kg/m2) < 20 and in men with an index > or = 30. However, risk of cardiovascular death, heart attack, and diabetes increased progressively from an index of < 20 even after age, smoking, social class, alcohol consumption, and physical activity were adjusted for. For the combined end point the lowest risks were seen for an index of 20.0-23.9. In never smokers and former smokers, deaths from any cause rose progressively from an index of 20.0-21.9 and for the combined end point, from 20.0-23.9. Age adjusted levels of a wide range of cardiovascular risk factors rose or fell progressively from an index < 20.
CONCLUSION: A healthy body mass index in these middle aged British men seems to be about 22.

Entities:  

Mesh:

Year:  1997        PMID: 9158466      PMCID: PMC2126570          DOI: 10.1136/bmj.314.7090.1311

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  31 in total

Review 1.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

Review 2.  Helping an obese patient make informed choices.

Authors:  C D Mulrow
Journal:  BMJ       Date:  1998-07-25

3.  Evaluation of indices of obesity in men: descriptive study.

Authors:  D Pounder; D Carson; M Davison; Y Orihara
Journal:  BMJ       Date:  1998-05-09

Review 4.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Diabetes and ethnic minorities.

Authors:  J Oldroyd; M Banerjee; A Heald; K Cruickshank
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

6.  Assessing the effectiveness and cost effectiveness of adaptive e-Learning to improve dietary behaviour: protocol for a systematic review.

Authors:  Phil Edwards; Lambert Felix; Jody Harris; Elaine Ferguson; Caroline Free; Jane Landon; Karen Lock; Susan Michie; Alec Miners; Elizabeth Murray
Journal:  BMC Public Health       Date:  2010-04-21       Impact factor: 3.295

7.  Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population.

Authors:  Jin-Sun Park; Sung-Gyun Ahn; Jung-Won Hwang; Hong-Seok Lim; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jea Tahk; Joon-Han Shin
Journal:  Cardiovasc Diabetol       Date:  2010-07-07       Impact factor: 9.951

8.  Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study.

Authors:  Azadeh Zabetian; Farzad Hadaegh; Parvin Sarbakhsh; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-05-13       Impact factor: 3.295

Review 9.  Fat or fit: what is more important?

Authors:  Vojtech Hainer; Hermann Toplak; Vladimír Stich
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review.

Authors:  Charles Agyemang; Juliet Addo; Raj Bhopal; Ama de Graft Aikins; Karien Stronks
Journal:  Global Health       Date:  2009-08-11       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.